World Articles in Ear Nose and Throat 
Treatment of Acoustic Neuroma - World Articles in Ear, Nose and Throat
 
Health Watch USA
Recommended Link


Acoustic Neuromas
Two Case Reports and Short Literature Review
 

Authors:  G. Vyas *, Sudhakar Vaidya ***, Ashish Sharma**
* Professor & Head Department of Medicine, ** Associate Professor, ***Associate Professor Department of ENT,

Institution:   R.D. Gardi Medical College, Ujjain, India.

Corresponding Author:   Dr. S. Vaidya,  R.D. Gardi Medical College, Ujjain, India.   E-Mail: drsvaidya@hotmail.com

Abstract: Acoustic neuormas are relatively uncommon benign tumors of the posterior fossa.  Treatment options include surgery, radiosurgery and observation.  Two patients with an acoustic neuroma are described, one of whom elected to have surgery the other radiosurgery.  Both patients presented with an asymmetric hearing loss.  The signs and symptoms and a short literature review are also presented.

Introduction:  In 1917, Harvey Cushing reported 30 cases of acoustic neuromas who underwent a suboccipital intracapsular removal with a marked reduction in intraoperative mortality to 10 to 15%.1  In 1922, Walter Dandy, Cushing's pupil, reported the first complete resection of an acoustic neuromas with a 11% mortality rate.1,2  Major improvements in outcomes occurred with the introduction of the operative microscope and surgical drill by Dr. William House.1   With the advent of meticulous microsurgical dissection, surgical clips and bone wax, the mortality for acoustic neuroma surgery dropped from 15% in 1917 to 1%.1

Acoustic neuromas occur at a frequency of approximately 1/100,000 per year.3   In the USA two to three thousand new cases are diagnosed each year and acoustic neuromas can be found in up to 1% of autopsies.3   They comprise 6% to 8% of all intracranial tumors and 80% to 90% of all CPA tumors.2   The vast majority occur in adulthood with no race or gender predilection. 

Most acoustic neuromas are benign schwannomas arising in the internal auditory canal, most commonly from the the vestibular division not the auditory division of the VIIIth cranial nerve.2  They are, thus, more appropriately called vestibular schwannomas.2  Malignant degeneration is very rare.    The following is a report of two patients with a cisternal acoustic neuroma. 

Case Report #1:  A 55-year-old male nonsmoker, nonalcoholic, nonhypertensive, nondiabetic, stenotypist by occupation presented with complaints of unilateral hearing loss right ear, tinnitus for the last three years.   There is no history of headache, trauma, convulsions, or projectile vomiting.  There is no history of tuberculosis, diabetes mellitus, hypertension or any other chronic illness in the past.  He had been previously diagnosed and treated as a case of cardiomyopathy.    For the complaints of hearing loss in right ear, tinnitus for last three years, he had been consulted by various ENT consultants and was subjected to all relevant investigations including audiometery which revealed unilateral deafness.

On April  3, when he was returning from his office work he lost consciousness which lasted for almost 10 minutes.  There was no neurological deficit at that time except sustained injury on left side due to the fall.  He was subjected to all routine investigations and MRI.  MRI revealed acoustic neuroma with intracanalicular extension.  All other routine investigations were found to be within normal limits.

Due to his medical condition, Gamma Knife Radiosurgery was advised as the primary treatment option to achieve tumor control and preserve facial nerve function.

Patient was shifted to Gamma Knife suite and Leksell stereotactic head frame was applied under sedation in supine position.    The skull measurements were recorded and imaging of head [stereotactic MRI] was obtained.  The radiological images were then network transferred to Gamma Plan and treatment planning was performed. Total five shots were delivered using two 18 mm collimator shots, and three 8 mm collimator shots.  100% of tumor volume [4.1 cubic cms] was delivered prescription dose greater than or equal to 12.0 Gy at 50% prescription isodose configuration.  Maximum dose to the tumor was 24.0 Gy.  Patient tolerated the procedure well.   Below is a collection of MRI images of the patient's acoustic neuroma.

ABR in Acoustic Neuroma - IT5 = 0.71 msCase Report #2:  The pictures below are MRI scans from a 47-year-old male patient (#2) with a left acoustic neuroma.  The only symptom was a very small asymmetrical hearing loss.  An ABR was performed which was abnormal, having a wave V intraaural latency of 0.71 ms.  The patient initially declined surgery and was followed for three years.  Tumor growth was detected and the neuroma was surgically excised through a left retromastoid craniectomy.   Right hand picture - Patient's audiogram.    Middle Picture - T1 MRI Scan with Gadolinium Contrast.   Left hand picture - T1 Weighted MRI Scan with Gadolinium Contrast.   
Click on Pictures to Enlarge:

 

  
 
Acoustic Neuroma - MRI Scan   Acoustic Neuroma - MRI Scan T1  Audogram - Acoustic Neuroma

 
Discussion:
 
  The etiology of most acoustic neuromas are idiopathic, rarely they are congenital.  However, All patients should be screened for neurofibromatosis.  Type 2 neurofibromatosis may present with bilateral acoustic neuromas.   Other possible associations with acoustic neuroma formation which can be found in the literature are loud noises4 and cell phone usage.5 

The most predictive symptoms are an asymmetric hearing loss at 3000 Hz of 15 dB or greater, asymmetrical discrimination and asymmetrical vestibular testing without vertigo.6  The second reported case is a patient with a minor asymmetric hearing loss that was found on MRI scan to have an acoustic neuroma.  Even patients with a history of noise induced hearing loss should have an MRI if their hearing loss is asymmetrical.  Baker et al7 has shown such patients have a 2.5% incidence of an acoustic neuromas on MRI scan.  

All patients with a significant asymmetrical hearing loss should undergo MRI scanning.   Daniels et al.8 reported finding 56 acoustic neuroma out of 1070 patients who underwent MRI testing for asymmetrical hearing loss.  In addition he found another 70 intra intracranial and inner ear lesions, including 27 cerebellopontine angle lesions and one case of multiple sclerosis. 

Poor balance is a common presenting complaint1, but since the growth of an acoustic neuroma is slow, the patient usually compensates for the loss of vestibular function and true vertigo is usually seen.  If the vascular supply to the inner ear is suddenly compromised by the tumor, vertigo and a sudden hearing loss may result.  

Treatment modalities can be divided into three types: Surgery, Radiosurgery, and Conservative.  Which modality that is recommended depends upon the size of the tumor, age of the patient and patient preference.  

Radiosurgery (Case Report #1):   Gamma knife radio surgery has become an accepted treatment modality for acoustic neuromas.  Reports of hearing preservation in patients with serviceable hearing, have ranged from 57%9 to 68%10 to 71%11.  Over 96% of patients have preservation of facial nerve function after treatment.12  An increase in hearing and facial nerve function preservation is found in patients treated with 13 Gy or less at the tumor margin.9,11,12   Long term complications from treatment with the gamma knife can rarely occur such as rupture of intracranial artery aneurysms.13 and hyrocephalus.14  The University of Pittsburg reported on 162 patients followed for 10 years only 4 required operation for tumor growth.14

Surgery (Case Report #2) :  Many patients with an acoustic neuroma have a profound hearing loss upon presentation.  However, if diagnosed early, auditory function may be good.  Noudel et al.15 reports that hearing can be preserved in 45% of patients, regardless of the surgical approach used.  Chin et al.16 reported that overall facial nerve function was normal or near normal in 83.5% of patients.  Those patients with small or medium sized tumors had 100% preservation.  The use of intraoperative monitoring has been shown to decrease the incidence of facial paralysis.17   Facial nerve function can be preserved in the majority of surgical cases.  The incidence of recurrence after transtemporal or translabyrinthine approach has been reported by Brors et al.18 to be 7%.  

Conservative:    A number of studies have studied the utility of following acoustic neuromas conservatively.19-21   Shin, et al.21 reported that of 97 patients 62% were successfully treated conservatively with a mean follow-up of 31 months.  Martin et al.22 reported that of 276 patients who had at least one follow-up MRI scan 22% had observed growth.  Some patients had rapidly growing tumors and follow-up scans starting at 6 months after treatment, yearly for two years and every five years after that were recommended.  Patients with cystic acoustic neruormas appeared to have a propensity for tumor growth20 and are often not considered good candidates for conservative treatment. 

In general, small tumors in older patients are best treated conservatively.  Patient in poor health are often better candidates for radiosurgery as opposed to surgery.  Large tumors, greater than 50 cc, and those associated with neurofibromatosis are better surgical candidates.  Regardless of the type of treatment all patients need to be followed by serial MRI scans the first of which should be 6 months to one year after treatment.  Long term complications and recurrences can result, thus requiring long term follow-up of patients. 
 

Conclusions:   Acoustic neuormas are slow growing benign tumors which most commonly present with an asymmetrical hearing loss.  Asymmetry as little as 15 dB may be the only symptom of the tumor.  Treatment recommendations will vary depending upon the health and age of the patient along with the size of the tumor. 
 

References:    

  1. Koerbel A, Gharabaghi A, Safavi-Abbasi S, Tatagiba M, Samii M. Evolution of vestibular schwannoma surgery: the long journey to current success. Neurosurg Focus. 2005 Apr 15;18(4):e10  View Reference

  2. Machinis TG, Fountas KN, Dimopoulos V and Robinson JS. History of Acoustic Neurinoma Surgery Medscape Today. Web reference last accessed 10/13/2009   View Reference

  3. Acoustic Neuroma, NIH Consensus Development Program. 1991 Dec; 9(4):1-24   View Article

  4. Hours M, Bernard M, Arslan M, Montestrucq L, Richardson L, Deltour I, Cardis E. Can loud noise cause acoustic neuroma? Analysis of the INTERPHONE study in France. Occup Environ Med. 2009 Jul;66(7):480-6. Epub 2009 Mar 15.  View Abstract

  5. Han YY, Kano H, Davis DL, Niranjan A, Lunsford LD. Cell phone use and acoustic neuroma: the need for standardized questionnaires and access to industry data. Surg Neurol. 2009 Sep;72(3):216-22; discussion 222. Epub 2009 Mar 27. View Abstract

  6. Saliba I, Martineau G, Chagnon M. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma. Otol Neurotol. 2009 Jun;30(4):515-21.  View Abstract

  7. Baker R, Stevens-King A, Bhat N, Leong P. Should patients with asymmetrical noise-induced hearing loss be screened for vestibular schwannomas? Clin Otolaryngol Allied Sci. 2003 Aug;28(4):346-51.  View Abstract

  8. Daniels RL, Swallow C, Shelton C, Davidson HC, Krejci CS, Harnsberger HR. Causes of unilateral sensorineural hearing loss screened by high-resolution fast spin echo magnetic resonance imaging: review of 1,070 consecutive cases. Am J Otol. 2000 Mar;21(2):173-80.  View Abstract 

  9. Yang I, Aranda D, Han SJ, Chennupati S, Sughrue ME, Cheung SW, Pitts LH, Parsa AT. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci. 2009 Jun;16(6):742-7. Epub 2009 Mar 20.   View Abstract 

  10. Myrseth E, Møller P, Pedersen PH, Lund-Johansen M. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery. 2009 Apr;64(4):654-61; discussion 661-3.  View Abstract

  11. Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009 Mar 13. [Epub ahead of print]   View Abstract 

  12. Yang I, Sughrue ME, Han SJ, Fang S, Aranda D, Cheung SW, Pitts LH, Parsa AT. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol. 2009 May;93(1):41-8. Epub 2009 May 9.   View Abstract

  13. Yamaguchi S, Kato T, Takeda M, Ikeda H, Kitamura K. Ruptured distal anterior inferior cerebellar artery aneurysm following stereotactic irradiation for vestibular schwannoma: case report. Neurol Med Chir (Tokyo). 2009 May;49(5):202-5.   View Abstract

  14. Acoustic Neuroma Treatment: Realities and Expectations. Department of Neurological Surgery. University of Pittsburg. Web reference last accessed 10/13/2009   View Reference 

  15. Noudel R, Ribeiro T, Roche PH. Microsurgical treatment of intracanalicular vestibular schwannomas. Prog Neurol Surg. 2008;21:183-91.  View Abstract

  16. Chen L, Chen L, Liu L, Ling F, Yuan X, Fang J, Liu Y. Vestibular schwannoma microsurgery with special reference to facial nerve preservation. Clin Neurol Neurosurg. 2009 Jan;111(1):47-53. Epub 2008 Oct 25.   View Abstract 

  17. Youssef AS, Downes AE. Youssef AS, Downes AE. Intraoperative neurophysiological monitoring in vestibular schwannoma surgery: advances and clinical implications. Neurosurg Focus. 2009 Oct;27(4):E9.   View Abstract

  18. Brors D, Schäfers M, Bodmer D, Draf W, Kahle G, Schick B. Postoperative magnetic resonance imaging findings after transtemporal and translabyrinthine vestibular schwannoma resection. Laryngoscope. 2003 Mar;113(3):420-6.   View Abstract 

  19. Malhotra PS, Sharma P, Fishman MA, Grumbine FL, Tholey R, Dam VQ, Dasgupta A, Pequignot E, Willcox TO. Clinical, radiographic, and audiometric predictors in conservative management of vestibular schwannoma. Otol Neurotol. 2009 Jun;30(4):507-14.   View Abstract 

  20. Martin TP, Senthil L, Chavda SV, Walsh R, Irving RM. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol. 2009 Apr;30(3):381-385.  View Abstract

  21. Shin YJ, Fraysse B, Cognard C, Gafsi I, Charlet JP, Berges C, Deguine O, Tremoulet M. Effectiveness of conservative management of acoustic neuromas. Am J Otol. 2000 Nov;21(6):857-62.   View Abstract

  22. Gerganov VM, Klinge PM, Nouri M, Stieglitz L, Samii M, Samii A. Prognostic clinical and radiological parameters for immediate facial nerve function following vestibular schwannoma surgery. Acta Neurochir (Wien). 2009 Jun;151(6):581-7; discussion 587. Epub 2009 Apr 1.    View Abstract
     

Advertisements
 

World Articles in Ear, Nose and Throat  www.waent.org                  Vol 3-1  Feb 1, 2010

Copyright WAENT 2010 All Rights Reserved
 

Advertisements

Advertisements

Google Ad space finances and sponsors ENT USAsm Websites.  ENT USAsm, Cumberland Otolaryngology or Dr Kevin Kavanagh, MD do not endorse, recommend, refer to or are responsible for the Advertisements or for the content or claims made in the Advertisements.